{"id":79016,"date":"2012-09-04T22:17:00","date_gmt":"2012-09-04T22:17:00","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/realizing-the-promise-of-rna-nanotechnology-for-new-drug-development.php"},"modified":"2024-08-17T15:25:32","modified_gmt":"2024-08-17T19:25:32","slug":"realizing-the-promise-of-rna-nanotechnology-for-new-drug-development-2","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanotechnology\/realizing-the-promise-of-rna-nanotechnology-for-new-drug-development-2.php","title":{"rendered":"Realizing the promise of RNA nanotechnology for new drug development"},"content":{"rendered":"<p><p>    ScienceDaily (Sep. 4, 2012)  The use    of RNA in nanotechnology applications is highly promising for    many applications, including the development of new therapeutic    compounds. Key technical challenges remain, though, and the    challenges and opportunities associated with the use of RNA    molecules in nanotechnology approaches are presented in a    review article in Nucleic Acid Therapeutics, a    peer-reviewed journal from Mary Ann Liebert, Inc.  <\/p>\n<p>    Peixuan Guo and colleagues, University of Kentucky, Lexington,    highlight the ability of RNA to self-assemble into    nanoparticles with diverse structures. In \"Uniqueness,    Advantages, Challenges, Solutions, and Perspectives in    Therapeutics Applying RNA Nanotechnology,\" the authors provide    a detailed description of the main challenges faced by the RNA    therapeutics industry, including the chemical and thermodynamic    instability of the molecules, potential safety and side effect    issues, difficulties in delivery and specific targeting, and    low yield and high production costs in manufacturing.  <\/p>\n<p>    \"The remarkable structural and enzymatic properties of RNA    continue to astound us,\" says Executive Editor Fintan Steele,    PhD, SomaLogic, Inc., Boulder, CO. \"It is exciting to see those    properties increasingly realized for the benefit of human    health and welfare, as described by Dr. Guo and his    colleagues.\"  <\/p>\n<p>    Nucleic Acid Therapeutics is under the editorial    leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, Duke    Translational Research Institute, Duke University Medical    Center, Durham, NC, and C.A. Stein, MD, PhD, City of Hope    National Medical Center, Duarte, CA; and Executive Editor    Fintan Steele, PhD, SomaLogic, Boulder, CO.  <\/p>\n<p>    Share this story on Facebook,    Twitter, and Google:  <\/p>\n<p>    Other social bookmarking and sharing tools:  <\/p>\n<p>    Story Source:  <\/p>\n<p>      The above story is reprinted from       materials provided by Mary Ann Liebert, Inc.,      Publishers, via AlphaGalileo.    <\/p>\n<p>      Note: Materials may be edited for content and length. For      further information, please contact the source cited      above.    <\/p>\n<p>    Journal Reference:  <\/p>\n<\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.sciencedaily.com\/releases\/2012\/09\/120904144850.htm\" title=\"Realizing the promise of RNA nanotechnology for new drug development\" rel=\"noopener\">Realizing the promise of RNA nanotechnology for new drug development<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> ScienceDaily (Sep. 4, 2012) The use of RNA in nanotechnology applications is highly promising for many applications, including the development of new therapeutic compounds. Key technical challenges remain, though, and the challenges and opportunities associated with the use of RNA molecules in nanotechnology approaches are presented in a review article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanotechnology\/realizing-the-promise-of-rna-nanotechnology-for-new-drug-development-2.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[7],"tags":[],"class_list":["post-79016","post","type-post","status-publish","format-standard","hentry","category-nanotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/79016"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=79016"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/79016\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=79016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=79016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=79016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}